Stephen Eeden to Neoplasm Staging
This is a "connection" page, showing publications Stephen Eeden has written about Neoplasm Staging.
Connection Strength
0.549
-
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.
Score: 0.247
-
Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900.
Score: 0.063
-
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
Score: 0.046
-
Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer. 2012 Jan; 20(1):65-73.
Score: 0.043
-
Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 2010 Jul; 184(1):120-5.
Score: 0.041
-
Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 2009 Sep; 74(3):509-15.
Score: 0.039
-
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
Score: 0.034
-
Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998 Jul 01; 90(13):986-90.
Score: 0.018
-
Racial differences in treatment of early-stage prostate cancer. Urology. 2008 Jun; 71(6):1172-6.
Score: 0.018